George Leonidis

George Leonidis


MSc, Chemist

George Leonidis is a PhD candidate at the organic chemistry laboratory of the chemistry department of Aristotle University of Thessaloniki. He graduated from the same university's chemistry department in 2016 after successfully completing his undergraduate thesis titled "Development of Small Molecule Palmitoylacyltransferase modulators of Sonic Hedgehog as anticancer agents" of the organic chemistry laboratory under the supervision of Professor Vasiliki Sarli. Two years later, he completed the postgraduate program "Organic Synthesis - Natural Products and Applications" with honors, specializing in organic and medicinal chemistry. During this time, he completed his master's thesis titled "Synthesis of c(RGDyK) peptide conjugates for cancer targeted drug delivery" under the guidance of Professor Vasiliki Sarli. George recently finished the experimental phase of his doctoral thesis, "Synthesis of Hybrid Molecules for Targeted Cancer Therapy," at Vasiliki Sarli's laboratory, where he worked under her supervision.

Since 2018, he has been the lead author of two research papers and a co-author of three research papers, two review papers, and a chapter in a scientific book. All of his works are published in international scientific journals with topics in medicinal and organic chemistry (h-index: 3, total citations: 49, total impact factor: 33.2, average impact factor: 5.5).

From February 2023, he is a Research Associate of the project “Individualised Medicine & Pharmacological Research Solutions Center (IMPReS)” (MIS 5047189) which is implemented under the Action “Support for Regional Excellence”, funded by the Operational Program “Competitiveness, Entrepreneurship and Innovation” (NSRF 2014–2020), under the scientific supervision of Professor of Pharmacology, Pharmacogenomics, and Precision Medicine, and Director of the Pharmacology Laboratory, Dr. Evangelos Manolopoulos.

His research interests involve the application of bioanalytical techniques to investigate metabolomic and proteomic studies, as well as their integration with medicinal chemistry.